Hay fever is a term commonly used to refer to allergic rhinitis caused by seasonal exposure to pollen. Allergic rhinitis can cause significant irritation and interference in a sufferer's daily activities, considerably reducing their quality of life. It is one of the most common chronic respiratory conditions in Australia, affecting around 15% of Australians or 3.1 million people. The amount of money paid by community pharmacies to wholesalers for medications commonly used to treat allergic rhinitis doubled between 2001 ($107.8 million) and 2010 ($226.8 million).
ISBN 978-1-74249-228-5; Cat. no. ACM 23; 50pp.; Internet Only
Publication table of contents
- Preliminary material
- Title and verso pages
- Causes and exacerbating factors
- Use of medications
- Management in hospital
- Other conditions that commonly occur together with allergic rhinitis
- Body section
- 1 Introduction
- 1.1 Relationship to other conditions
- 1.2 Structure of report
- 2 What causes and worsens allergic rhinitis?
- 2.1 Genetic factors
- 2.2 Age
- 2.3 Early life factors
- 2.4 Allergen exposure
- 2.5 Pollutants
- 2.6 Occupational exposures
- 3 Who has allergic rhinitis?
- 3.1 Age and sex
- 3.2 Geography
- 3.3 Country of birth
- 4 How is allergic rhinitis managed?
- 4.1 Use of medications for management of allergic rhinitis
- 4.2 Management of allergic rhinitis in general practice
- 4.3 Management of allergic rhinitis in hospital
- End matter
- Appendix A: Definitions and data sources for medication data
- A1 Regulatory control of medication supply
- A2 Medication data
- Data extraction for medicines used to manage allergic rhinitis
- Data items in IMS Health data
- A3 Defined daily dose as a measure of drug utilisation
AIHW 2011. Allergic rhinitis ('hay fever') in Australia. Cat. no. ACM 23. Canberra: AIHW. Viewed 1 May 2017 <http://www.aihw.gov.au/publication-detail/?id=10737420595>.